Nadine Bley

9PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursMedical infection agents (incl. prions)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 24, 2026
Sex determines the natural killer cell-mediated immunity against pancreatic cancer.

Elise Arlt, Nadine Bley, Alexander Rausch

|Dec 24, 2025
Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer.

Nadine Bley, Alexander Rausch, Simon Müller

|Feb 26, 2025
The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer.

Annekatrin Schott, Theresa Simon, Simon Müller

|Feb 01, 2024
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing.

Alice Wedler, Nadine Bley, Markus Glaß

|Sep 30, 2022
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.

Johanna Stachelscheid, Qu Jiang, Christoph Aszyk

|Jul 18, 2022
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis.

Neus Mestre-Farràs, Santiago Guerrero, Nadine Bley

Pageof 2